>O31663 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MGVTKTPLYETLNESSAVALAVKLGLFPSKSTLTCQEIGDGNLNYVFHIYDQEHDRALII
KQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVMEDLSHL
KIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERL
VFTDPFFDHDTNDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIF
ASEHETKVIDPEFAFYGPIGFDVGQFIANLFLNALSRDGADREPLYEHVNQVWETFEETF
SEAWQKDSLDVYANIDGYLTDTLSHIFEEAIGFAGCELIRRTIGLAHVADLDTIVPFDKR
IGRKRLALETGTAFIEKRSEFKTITDVIELFKLLVKE
>Q9F0P1 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSQYHTFTAHDAVAYAQQFAGIDNPSELVSAQEVGDGNLNLVFKVFDRQGVSRAIVKQAL
PYVRCVGESWPLTLDRARLEAQTLVAHYQHSPQHTVKIHHFDPELAVMVMEDLSDHRIWR
GELIANVYYPQAARQLGDYLAQVLFHTSDFYLHPHEKKAQVAQFINPAMCEITEDLFFND
PYQIHERNNYPAELEADVAALRDDAQLKLAVAALKHRFFAHAEALLHGDIHSGSIFVAEG
SLKAIDAEFGYFGPIGFDIGTAIGNLLLNYCGLPGQLGIRDAAAAREQRLNDIHQLWTTF
AERFQALAAEKTRDAALAYPGYASAFLKKVWADAVGFCGSELIRRSVGLSHVADIDTIQD
DAMRHECLRHAITLGRALIVLAERIDSVDELLARVRQYS
>Q81MJ5 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MGYYSLTEVTAVQYAKEHGYFEKKANVVCHEIGDGNLNYVFKLDDGEKSIIIKQALPYAK
VVGESWPLSIKRATIESKALQIFAKYVPEYVPVVYSHDEELAVTVIEDLSRLTITRKGLI
DGEEYPLLSQHIGRFLANVLFYTSDFGLQSEEKRVLEGTFVNPDLCKITEDLVFTDPFGH
YDTNDYEPELQLTIDELWSDKTLKLKVAQYKYKFLTRKEALIHGDLHTGSIFSSPSETKV
IDPEFATYGPFGFDIGQFIANLLLNALSREEEQRGVLFFHIEKTWSYFVETFTKLWIGEG
VEAYTKEKQWLPIILQNIFTDAVGFAGCELIRRTIGLAHVADLDEITNKETRIQAKKQAL
SLGKELIKYESKNADIQLFRTLFQQTVSGGIKA
>A7MKY0 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSQYRTFTASDAVAYAQQFGGLSAPEALVSAQEVGDGNLNLVFKIFDKQGISRIVVKQAL
PYVRCVGESWPLTLDRARLEAQTLVAHYQHCPAHTVKIHHYDPTLAVMVMEDLSDHRIWR
GELIKGVHYPQAARQLGEYLAQTLFHTSDFYLHPHAKKAEVARFINPEMCEITEDLFFND
PYQVHERNNYPAELEADVAALRDDAALKCAVAALKHRFFSHAEALLHGDIHSGSIFVADG
SLKAIDAEFGYFGPVGFDVGTAIGNLLLNYCGAPGQLGIREAADAREQRLIDIATLWHTF
AERFQTLAREKTRDAALAEPGYASEFLKKVWADAIGFAGTELIRRSVGLSHVADIDTIRD
EEMKLSCLRHAIGLGKALILLAPRIENADEFIARVRQYG
>A8ANI4 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSQYRTFTAQDAVEYARTFGGIDDPSTLVEAQEVGDGNLNLVFKIFDTTGVSRIVVKQAL
PYVRCVGESWPLTLDRARLEAQTLVAHYQHCPQHTVKIHHFDPELAVMVMEDLSDHNIWR
GELIKGAWYPQAARQLGEYLAQTLFHTSDFYLHPHDKKAQVATFINPEMCEITEDLFFND
PYQIHERNSYPAEIEGDVAALRSDAQLKLAVAALKHRFFSHAEALLHGDIHSGSIFVADG
RLKAIDAEFGYFGPIGFDVGTAIGNLLLNFCGLPGHLGIRDAAAAREQRLTDIQELWNTF
AERFQVLATEKTRDAALRAPGYASEFLKKVWADAIGFCGTELIRRSVGLSHVADIDTIQD
AEMRHECLRHAITLGKALIVIADRIESVEALIARVRQYS
>A9R2Z4 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSRYHTFTAADAVEYARQFGQVADPQALVTADEIGDGNLNLVFKIRDTAGISRVIVKQAL
PYVRCVGESWPLMLDRARIEAETLLTHSQFCPQHTVKVLHHDAELAVMVQEDLSDHHIWR
HELIQGNYYPQAAEQLGEYLAQTLFHTSDFYQSAQAKKAAVSRYTNPELCQITEDLFFTD
PYIEHERNNFDPVLLPEVLSLRQDKALKLAVASLKHRFLSQAEALLHGDIHSGSIFVADG
RLKTIDAEFGFYGPIGFDIGTALGNLLLNYCGLPGLAGPRDAAAGREQRLNDVQTVWQTF
AARFLALSQEKAQDPALATEGYAAQFLQHVWRDAIGYCGSELIRRTIGLAHVADLDSIDD
QEMRRACQRHALSLGRALILVAPHVDDVGGVVARIRQSPSSLTPQRC
>Q6D1H0 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSLYRTFTADDAVEYARQYGGVSQPQTLVTAEEIGDGNLNLVFKIKDEAGISRVIVKQAL
PYVRCVGESWPLTLDRARIEAETLLTHARFCPQHTVTVLYHDPELAVMVQEDLSDHRIWR
SELVRGADYPQAAAQLGEYLAQTLFHTSDFYQHPHEKKAAVSQFTNPELCEITEDLFFTD
PYIDHERNQFDAALTPDVQTLRDDRALKLAVAGLKHRFLSKAEALLHGDIHSGSIFVAEG
RLKVIDAEFGFYGPMGFDIGTAIGNLLLNYCGLPGLLAPREAAAGRERRLEDIRTLWQTF
SARFLALSESDCREPALAESGYAALFLQQVWLDAIGFCGTELIRRTIGLAHVVDLDSIQE
TDARLACQRHVLSLGRTLVLAAPHIADVDALLARVRQSGA
>A1JP08 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSRYHTFTAADAVEYARQFGQIADPLALVTADEIGDGNLNLVFKIRDAAGMSRVIVKQAL
PYVRCVGESWPLTLDRARIEAETLLTHGQFCPQHTVNVLHHDAELAVMVQEDLSDHEIWR
SELVKGKYYPQAAGQLAEYLAQTLFHTSDFYQSAQAKKAAVSRYTNPELCQITEDLFFTD
PYIDHERNNFDPALLPEVLALRQDDALKLAVASLKHRFLSKAEALLHGDIHSGSIFVADG
RLKAIDAEFGFYGPIGFDVGTALGNLLLNYCGLPGLAGPRDAAAGREQRLKDIHILWETF
SHRFLALCEEKTQDSTLATAGYARLFLQQVWQDAVGYCGSELIRRTIGLAHVADLDSIAD
DEMRRACQRHALSLGRTLILAASRIDSIDDLIARIRQNG
>A7GS57 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MGYYALTEETAVQYVKEQGYFEKEATIVCREIGDGNLNYVFHLHDGKRGIIVKQALPYAK
VVGESWPLSLNRATIESSALQIFAKYVPEFVPKVYGHDKELAVIVMEDLSSLTIVRKGFI
EGEEYPLLSEHVGRFLGKVLFYTSDFGLNTEEKRVLDGKFINPDLCKITEDLVFTDPFGN
YETNDYERELQSVIEELWCDKNLKLQVAQYKYKFLTRKEALIHGDLHTGSIFASSKETKI
IDPEFATFGPLGFDLGQFIANLLLNALSREEKREVVFFHIEKTWSYFVDTFTKLWILEGV
ETYTKEKQWLPIVLQHIFRDAVGFAGCEVIRRTIGLAHVVDLDGIVEKDRRIQVKKQALY
LGRSLLLHQTKGADIQVFKTLFQHIVSEGGIKV
>Q5L1E5 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MTTVQTSVYEPLTEPKAVALAVRLGLFRDGTPLACREIGDGNLNLVFHIVDQETKQGVII
KQALPYAKVVGESWPLTLKRAVIESNALRTFASYVPQYVPKVYYSDESLAITVMEDLSRL
QIARKGLIEGKTYPLLSQHIGEFVAKTAFYTSDFGMNQQEKKKLAQSFVNPELCKITEDL
VFTDPFFDHETNNFEDELRPDVEALWRDDRLHLEAAKLKRKFLTEADVLLHGDLHTGSIF
VSADETKVIDPEFAFYGPIGFDLGQFFANLLLNALSRSELERQPLFDHIDRTWDVFASVF
SNLWRTESVETYAATPGLLEDVLRHAFIDAVGFAGCEVIRRTIGLAHVADLDGIEHKDER
LVAKRHALRLGRRLIIERRVFTGTEDFRRLFAETEQ
>B1YIY3 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MGYQAFTVQDAIERVRTLGLIGNEPVTAEEIGDGNLNLVFRIQAGEKRLILKQALPYAKV
VGESWPLSLERAWIEQSALKEFAKVAVPFVPHVYHASKEEAFTVMEDLSHLTIVRGGLLE
GEKYPLLAEHIGSYLARTLFYTSDFAVGPVAKKQIARQYYNPDLCDITEKLIFTDPFYDA
ETNAIEAGLEAEVDRIWNDAELKREVAKLEALFITKGDALLHGDLHTGSIFASAEETKVI
DPEFAFYGPFGFDVGQFIAHLFFAAYPDYDRLRDERIKDIDTFWLTFASTFKALWEREAV
EPFRKADGLVDDVLSTILQDALGFAGCELIRRTIGLALVADLEQISDSTVRLERKRHALR
LGAALIKRRTECKTFTDLRNFDVTEELSR
>A8FCG6 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MVTLTASYEELTESSAVALAIRLGLIQESSHLTCTEIGDGNLNYVFHIFDHKQEKGLIIK
QALPYAKVVGESWPLTLDRARIESAALIKQSEYTPHLVPAVYYSDTALAVTAMEDLSHLE
IVRKGLIAGKQYPHLSDHVGEFLGKTLFYTSDFATNPKIKKQFVKQFTNPDLCDITEKLV
FTDPFFDSSTNDFEEELREAAEALWADLEVQAKAAELKRIFLTSAETLVHGDLHTGSIFA
SETETKIIDPEFAFYGPFGFDIGHFIANLFLNALSRENEHDQQHLFDHVVNVWATFKEVF
AKAWKEDSIEAFSVSDSFLETTFDRILKEATGFAGCELVRRTIGLAHAADLDAIPSPSKR
IQQKKTALTLGKTFIKQYHAVETASDLVALFQQSVKE
>A4ILL2 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MAIIQSSAYEPLTEQKATALAVRLGLFRDGTPLLCREIGDGNLNLVFHVVDQETKQGIII
KQALPYAKVVGESWPLTLKRAVIESNALRTFASYVPQYVPKVYYSDESLAITVMEDLSYL
QIARKGLIEGKTYPLLSRHIGEFIAKTAFYTSDFGMNQQEKKKLAQSFVNPELCKITEDL
VFTDPFFDHDSNNFEDELHLDVETLWNDDRLHLEAAKLKRKFLTEADVLLHGDLHTGSIF
ASDDETKVIDPEFAFYGPIGFDLGHFIANLLLNALSRPESERRPLFDHIDRTWAVFTSVF
SELWRTESVETYAATPGLLDDVLRQTFIDAVGFAGCEVIRRTIGLAHVADLDGIEQKDER
LAAKRHALRLGRRLIVERAELDGTEDFRRLFVETER
>Q65KK1 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MTVTKTAAYETLTESSAAALAVRLGLFPSKSTLTCREIGDGNLNLVFRVYDKEQQRGLVI
KQAVPYAKVVGESWPLTLDRARIESSALIRQAEHVPHLVPKVYYSDTELAVTVLEDLSHL
EIARNGLIDGKDYPHLSEDIGEFLGKTHFYSSEYALDPTVKERLVKQFTNPDLCDITESL
VFTDPFFDHETNDFEEELRDEAEVLWGNEALKIEAAKLKQRFLSAEETLIHGDLHTGSIF
AGEDGETKIIDPEFAFFGPIGFDIGQFIANLLLNALSREENRRAPLYRHVETVWNTFSRT
FSEAWENDAVETCKHENGRLESVLRQAFEDAAGFAGCEMIRRTIGLAHVADLDTIVPFSR
RISQKKLALKIGAAFIEKRSGFRTPKDMIEAFRNALKE
>A8GAB2 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSHYRTFTAADAVEYARQYGQLADPQALVSADEIGDGNLNLVFKIRDRDGVSRVIVKQAL
PYVRCVGESWPLTLDRARIEAETLLIHGGFCPRHTVKVLHHDAELAVMVQEDLSDHHIWR
SELVKGHYYPLAAGQLAEYLAQTLFHTSDFYQTAQEKKAEVSRFSNPELCQITEDLFFTD
PYIDHERNQFDPALLPQVLELRNDAALRLAVAGLKHRFLSKAEALLHGDIHSGSVFVAEG
KLKAIDAEFGFYGPIGFDVGTALGNLLLNYCGLPGLFGPRDAAAGREQRLQDVRELWLIF
ADRFLALCHQQTREAALAVPGYAEQFLQQVWTDAVGYCGSELIRRTIGLAHVADLDSISD
AEMRAECQRNALGLGRALIVNAPQIEHIDALLARIRQNG
>C5D7U6 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MPVSHPTVYEPLTEQGAISLAVRLGLFPEGTPLACREIGDGNLNLVFRVVDQQTKKGIIV
KQALPYAKVVGESWPLTLKRAVIESNALRTFASYVPQYVPKVYYSDESLAITVMEDLSHL
QIARKGLIEGKTYPLLSQHIGEFIAKTSFYTSDFGMNQQEKKQLAQSFVNPELCKITEDL
VFTDPFFNHETNNFEDELRDDVEALWNDDKLHLEAAKLKRKFLTEGDALIHGDLHTGSIF
ASDEETKIIDPEFAFYGPFGFDIGQFFANLLLNALSRPEQQQEPLFAHIDKTWDVFSTVF
SDLWRTHNVEPYAKTEGLLEDVLHHTFIDAIGFAGCEVIRRTIGLAHVADLDGIEDKEER
LQAKRYALRLGRSLILQRETLSSTKEIRSLFAQTVLAATN
>Q819F1 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MGYYSLTEITAVQYAKDYGYFEEKANVICHEIGDGNLNYVFKLDDGEKSIIIKQALPYAK
VVGESWPLSIKRATIESKALQIFAQYVPDYVPVVYSHDEELAITVIEDLSRLTITRKGLI
DGEEYPLLSQHIGRFLAHVLFYTSDFGLQSEEKRILEGTFVNPDLCKITEDLVFTDPFGH
YDTNDYEPDLQLVVDELWSDKTLKLKVAQYKYKFLTRKETLIHGDLHTGSIFSSPSETKV
IDPEFATYGPFGFDIGQFIANLLLNALSREEEKRSVLFFHIEKTWSYFVETFTKLWIGEG
VEAYTKEKQWLPIILQNIFTDAVGFAGCELIRRTIGLAHVADLDEIENKETRIQAKKQAL
SLGKELIKYESKSADIQLFRTLFQQTVSRGVKA
>A4W7Z0 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MSQYRTFTAQDAVEYAKQFGGLDNPSSLVEAQEIGDGNLNLVFKIFDAQGVSRIIVKQAL
PYVRCVGESWPLTLDRARLEAQTLVEHYQHSPQHTVKIHHYDPELAVMVMEDLSSHKIWR
GELISGVYYPQASRQLGEYLAHTLFHTSDFYLHPHAKKAQVAKYINPEMCEITEDLFFND
PYQIHERNNYPAELEADVAALRSDDQLKIAVASLKHRFFSQAEALLHGDIHSGSIFVAED
SLKAIDAEFGYYGPIGFDIGTAIGNLLLNFCGLPGHLGIRDAAAAREQRLTDIQELWNTF
SERFQALATEKTRDAALSVPGYASQFLKKVWTDAIGFCGTELIRRSVGLSHVADIDTIKD
DAMRHECLRHAITLGKALIVIADRIDSAEALVARVRQYS
>Q6HED2 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MGYYSLTEVTAVQYAKEHGYFEKKANVVCHEIGDGNLNYVFKLDDGVKSIIIKQALPYAK
VVGESWPLSIKRATIESKALQIFAKYVPEYVPVVYSHDEELAVTVIEDLSRLTITRKGLI
DGEEYPLLSQHIGRFLANVLFYTSDFGLQSEEKRVLEGTFVNPDLCKITEDLVFTDPFGH
YDTNDYESELQLAVDELWSDKILKLKVAQYKYKFLTRKEALIHGDLHTGSIFSSPSETKV
IDPEFATYGPFGFDIGQFIANLLLNALSREEEQRGVLFFHIEKTWSYFVETFTKLWIGEG
VEAYTKEKQWLPIILQNIFTDAVGFAGCELIRRTIGLAHVADLEEITNKETRIQAKKQAI
SLGKELIKYESKNADIQLFRTLFQQTVSGGIKA
>A9VFD6 Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)
MGYYSLTETTAIQYAKEHGYFEKKANVVCHEIGDGNLNYVFKLDDGEKSIIIKQALPYAK
VVGESWPLSIKRATIESKALQIFAKYVPDYVPVVYSHDEELAVTVIEDLSRLTITRKGLI
DGEGYPLLSQHIGRFLAHVLFYTSDFGLQSEEKRVLEGTFVNPDLSKITEDLVFTDPFGH
YDTNDYESDLQSVIDELWSDKTLKLKVAQYKYKFLTRKEALIHGDLHTGSIFSSPSETKV
IDPEFATYGPFGFDIGQFIANLLLNALSREEEKRSVLFFHIEKTWSYFVENFTKLWIGEG
VEAYTKEKQWLPIILQNIFTDAVGFAGCELIRRTIGLAHVADLDGIANKENRIQAKKQAL
SLGRELIKYEAKCADIQLFRTLFQQTVGGVKA
